VisionGate Announces an Exclusive Global License, Manufacturing and Supply Agreement for Iloprost, VisionGate’s Phase 2 Oral Lung Cancer Interception Drug

Press Release, August 22, 2019



more No Comments August 22 2019


VisionGate® Presents Blinded Trial Data at WCLC 2016: Could Help Alleviate Worry Over Incidental Lung Nodule Findings


more No Comments December 16 2016


17th World Conference on Lung Cancer: VisionGate Will Present Twice!


more No Comments November 17 2016


VisionGate to speak for the exclusive Piper Jaffray Conference


more No Comments November 17 2016


VisionGate Hires Renowned Chief Medical Officer Dr. Javier Zulueta


more No Comments June 2 2016


VisionGate’s LuCED Test and New Drug Therapy to Prevent Lung Cancer


more No Comments June 1 2016


Lung Cancer Pioneers Create Lung Cancer Eradication Pact: VisionGate Acquires Exclusive Rights to University of Colorado’s Chemoprevention Drug Iloprost


more No Comments January 7 2016


VisionGate’s LuCED Shows Promise for Lung Cancer Screening


more No Comments September 11 2015


Significant Lung Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology


more No Comments July 9 2015


World renowned surgeon joins VisionGate’s Medical Advisory Board


more No Comments April 1 2015



Copyright 2020 - VisionGate, Inc.